Prognostic Significance of Immunohistochemical Expression of p53 Gene Product in Operable Breast Cancer
Hong Suk Song, Young Rok Do, Sun Hee Kang, Ki Yong Jeong, Yu Sa Kim
Cancer Res Treat. 2006;38(4):218-223.   Published online 2006 Dec 31     DOI: https://doi.org/10.4143/crt.2006.38.4.218
Citations to this article as recorded by Crossref logo
Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases
Amber N. Hurson, Mustapha Abubakar, Alina M. Hamilton, Kathleen Conway, Katherine A. Hoadley, Michael I. Love, Andrew F. Olshan, Charles M. Perou, Montserrat Garcia-Closas, Melissa A. Troester
npj Breast Cancer.2022;[Epub]     CrossRef
Comparison of histopathological grading and staging of breast cancer with p53-positive and transforming growth factor-beta receptor 2-negative immunohistochemical marker expression cases
PalashKumar Mandal, Anindya Adhikari, Subir Biswas, Amita Giri, Arnab Gupta, Arindam Bhattacharya
Cancer Translational Medicine.2020; 6(2): 30.     CrossRef
Evaluation of p53 in breast cancer and its correlation with various histological prognostic factors
Kriti Arora, Ruchee Khandelwal, Hema Pant
Indian Journal of Pathology and Oncology.2020; 7(3): 392.     CrossRef
Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients
Rahmawati Pare, Patsy S. Soon, Aashit Shah, Cheok Soon Lee, Aamir Ahmad
PLOS ONE.2019; 14(4): e0214604.     CrossRef
Immunohistochemical expression levels of p53 and eIF4E markers in histologically negative surgical margins, and their association with the clinical outcome of patients with head and neck squamous cell carcinoma
JAGTAR SINGH, RAMA JAYARAJ, SIDDHARTHA BAXI, MARIANA MILEVA, JOHN SKINNER, NAVNEET K. DHAND, MAHIBAN THOMAS
Molecular and Clinical Oncology.2016; 4(2): 166.     CrossRef
Updated overview of current biomarkers in head and neck carcinoma
Kiran Dahiya, Rakesh Dhankhar
World Journal of Methodology.2016; 6(1): 77.     CrossRef
Evaluation of p53, HoxD10, and E-Cadherin Status in Breast Cancer and Correlation with Histological Grade and Other Prognostic Factors
Preethi Sekar, Jyotsna Naresh Bharti, Jitendra Singh Nigam, Ankit Sharma, Priyanka Bhatia Soni
Journal of Oncology.2014; 2014: 1.     CrossRef
An Australian Retrospective Study to Evaluate the Prognostic Role of p53 and eIF4E Cancer Markers in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC): Study Protocol
Jagtar Singh, Rama Jayaraj, Siddhartha Baxi, Mariana Mileva, Justin Curtin, Mahiban Thomas
Asian Pacific Journal of Cancer Prevention.2013; 14(8): 4717.     CrossRef
Morphometric and Histological Study of Breast Lesions with Special Reference to Proliferative Activity and Invasiveness
Asim Kumar Manna, Aparajita Samaddar, Sumit Mitra, Swapan Pathak, Srabani Chakrabarti, Diptendra Kumar Sarkar
Indian Journal of Surgery.2013; 75(3): 204.     CrossRef
Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients
Mais M Al-Mumen, Asad A Al-Janabi, Alaa S Jumaa, Kaswer M Al-Toriahi, Akeel A Yasseen
BMC Research Notes.2011;[Epub]     CrossRef
Balance between SIRT1 and DBC1 expression is lost in breast cancer
Ji‐Youn Sung, Ranah Kim, Ja‐Eun Kim, Juhie Lee
Cancer Science.2010; 101(7): 1738.     CrossRef